Strengthening the Texas Medicaid Drug Utilization Review Program
December 15, 2010 The Texas Medicaid Drug Utilization Review Program helped the state save $16 million in fiscal year 2010 by seeking to optimize the use of atypical antipsychotic medications. The program, which started in fiscal year 2009 has also targeted other psychotropic medications and care management interventions to achieve cost savings. Download the Report . . .
